Artificial Intelligence in Precision Medicine Market Size Worth USD 38.88 Billion by 2034 | CAGR: 35.5%

BySheetal Gajbhiye

The global Artificial Intelligence in Precision Medicine market was valued at USD 1.87 billion in 2024, and it is projected to grow to USD 38.88 Billion by 2034. During the forecast period from 2025-2034, the market is estimated to rise at a compound annual growth rate (CAGR) of 35.5%. Key drivers of the artificial intelligence in precision medicine market include advancements in AI algorithms, increased availability of healthcare data, and growing demand for personalized treatment approaches. Notable trends fueling market growth include the adoption of AI-driven tools for genomic analysis, the integration of AI in drug discovery processes, and the rising use of virtual health assistants to support patient care. These innovations are accelerating the development and implementation of AI in precision medicine.

Market Definition

Artificial Intelligence (AI) in Precision Medicine refers to the use of advanced AI technologies—such as machine learning, deep learning, and natural language processing—to tailor medical treatment and care to the individual characteristics of each patient. This includes genetic makeup, lifestyle, environment, and disease biology, enabling more accurate diagnosis, prognosis, and therapy selection.

Key Report Highlights  

·         The report highlights the key region that accounts for the highest revenue share in the global Artificial Intelligence in Precision Medicine market.

·         It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.

·         The report outlines the dominant segment that holds a major share of the market.

·         It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.

·         Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

·         Market Value in [2024]: USD 1.87 billion

·         Projected Market Size in [2034]: USD 38.88 Billion

·         Anticipated CAGR 2034:  35.5%

Get access to the full report or request a complimentary sample for in-depth analysis: https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-in-precision-medicine-market/request-for-sample

Market Growth Drivers

One of the key drivers of the artificial intelligence in precision medicine market is the rapid advancement of AI algorithms and technologies. In recent years, machine learning and deep learning models have greatly enhanced their speed and accuracy, allowing for more effective analysis of large and complex healthcare datasets. These advanced algorithms can uncover patterns in genetic, clinical, and environmental data, supporting personalized treatment strategies and early disease prediction. For instance, AI tools can now assess genetic profiles to predict risks for conditions like cancer or diabetes. The growing capabilities of technologies such as natural language processing (NLP) and neural networks are further accelerating AI adoption in healthcare, paving the way for increasingly precise and individualized medical solutions.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include

  • ·         IBM Corporation
  • ·         Microsoft Corporation
  • ·         Google Health
  • ·         NVIDIA Corporation
  • ·         Tempus Labs
  • ·         Zebra Medical Vision
  • ·         Butterfly Network
  • ·         PathAI
  • ·         BenevolentAI
  • ·         Recursion Pharmaceuticals
  • ·         Illumina
  • ·         Siemens Healthineers
  • ·         GE Healthcare
  • ·         Philips Healthcare
  • ·         Foundation Medicine

Similar Posts